1
|
Central venous catheter (CVC)-related infections in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2003
|
1.62
|
2
|
Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.
|
J Clin Microbiol
|
2003
|
1.49
|
3
|
IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
|
Crit Care Med
|
2006
|
1.47
|
4
|
DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.
|
J Clin Microbiol
|
2007
|
1.25
|
5
|
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
|
Haematologica
|
2008
|
1.24
|
6
|
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
|
Antimicrob Agents Chemother
|
2013
|
1.19
|
7
|
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2008
|
1.17
|
8
|
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology.
|
Eur J Cancer
|
2009
|
1.13
|
9
|
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2003
|
1.11
|
10
|
Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.
|
Antimicrob Agents Chemother
|
2012
|
0.98
|
11
|
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
|
J Antimicrob Chemother
|
2008
|
0.98
|
12
|
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
|
J Infect
|
2007
|
0.97
|
13
|
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2013
|
0.96
|
14
|
Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
|
J Antimicrob Chemother
|
2012
|
0.92
|
15
|
Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates.
|
Ann Hematol
|
2007
|
0.92
|
16
|
Invasive aspergillosis: new insights into disease, diagnostic and treatment.
|
Curr Pharm Des
|
2013
|
0.91
|
17
|
Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2003
|
0.90
|
18
|
Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient.
|
Cancer Chemother Pharmacol
|
2003
|
0.90
|
19
|
Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase.
|
Eur J Haematol
|
2007
|
0.90
|
20
|
Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis.
|
PLoS One
|
2013
|
0.88
|
21
|
Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial.
|
Eur J Haematol
|
2010
|
0.87
|
22
|
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
|
Eur J Haematol
|
2005
|
0.87
|
23
|
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
|
Lung Cancer
|
2007
|
0.86
|
24
|
Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
|
Eur J Haematol
|
2012
|
0.85
|
25
|
IgA nephropathy and hodgkin's disease: a rare coincidence. Case report and literature review.
|
Am J Kidney Dis
|
2005
|
0.85
|
26
|
Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).
|
Ann Hematol
|
2014
|
0.84
|
27
|
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.
|
Mycoses
|
2011
|
0.83
|
28
|
Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients.
|
J Med Microbiol
|
2009
|
0.82
|
29
|
Dying in cancer centers: do the circumstances allow for a dignified death?
|
Cancer
|
2014
|
0.81
|
30
|
Central venous catheter-related infections in hematology and oncology : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2008
|
0.81
|
31
|
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2003
|
0.81
|
32
|
Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2012
|
0.81
|
33
|
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.
|
Ann Hematol
|
2015
|
0.81
|
34
|
Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
|
Ann Hematol
|
2014
|
0.81
|
35
|
Rapid treatment of leukostasis in leukemic mantle cell lymphoma using therapeutic leukapheresis: a case report.
|
ScientificWorldJournal
|
2011
|
0.80
|
36
|
Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors.
|
Onkologie
|
2009
|
0.80
|
37
|
Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS.
|
Electrophoresis
|
2009
|
0.80
|
38
|
Diagnostic yield of blood cultures from antibiotic-naïve and antibiotically treated patients with haematological malignancies and high-risk neutropenia.
|
Scand J Infect Dis
|
2009
|
0.79
|
39
|
Long-term survival in patients with acute leukemia and chronic disseminated candidiasis despite minimal antileukemic therapy.
|
Haematologica
|
2006
|
0.79
|
40
|
Interlaboratory comparison of PCR-based identification of Candida and Aspergillus DNA in spiked blood samples.
|
Mycoses
|
2012
|
0.78
|
41
|
Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions?
|
Mycoses
|
2007
|
0.78
|
42
|
Systematic identification of substrates for profiling of secreted proteases from Aspergillus species.
|
J Microbiol Methods
|
2007
|
0.78
|
43
|
Detection of Aspergillus DNA by a nested PCR assay is superior to blood culture in an experimental murine model of invasive aspergillosis.
|
J Med Microbiol
|
2004
|
0.78
|
44
|
Surgical interventions in patients with hematologic malignancies.
|
Crit Rev Oncol Hematol
|
2005
|
0.76
|
45
|
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
|
Ann Hematol
|
2003
|
0.76
|
46
|
Comparison of glucan detection and galactomannan enzyme immunoassay in gastrointestinal and systemic murine candidiasis.
|
Diagn Microbiol Infect Dis
|
2003
|
0.75
|
47
|
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2006
|
0.75
|
48
|
Hodgkin's lymphoma in a patient with cystic fibrosis: a clinical challenge.
|
Ann Hematol
|
2012
|
0.75
|
49
|
[Antifungal medication: new substances, new experiences].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
50
|
Characteristics, treatment and prognostic factors of patients with gynaecological malignancies treated in a palliative care unit at a university hospital.
|
Onkologie
|
2013
|
0.75
|
51
|
Prof. Dr. rer. nat. Johannes Müller February 18, 1927 to May 28, 2019.
|
Mycoses
|
2019
|
0.75
|
52
|
Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopenia.
|
Eur J Haematol
|
2004
|
0.75
|
53
|
Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.
|
Onkologie
|
2013
|
0.75
|